Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are already scheduled to have a heart rhythm procedure called pulmonary vein isolation (PVI) using a specific device called the FARAPULSE catheter ablation system
- People who have been diagnosed with a type of irregular heartbeat called paroxysmal atrial fibrillation (where the irregular rhythm comes and goes) within the last 6 months
- People who have had a longer-lasting form of irregular heartbeat (persistent atrial fibrillation) but whose heart rhythm has been brought back to normal — either on its own or with the help of medications — with no more than one electrical shock treatment (cardioversion) needed more than 7 days ago
Who may not be able to join:
- People who have had a stroke within the last 6 months
- People who have more than moderate damage to their heart valves that would require treatment
- People who have had a heart procedure (through a catheter or surgery) in the last 3 months, or have one already scheduled
- People who have previously had a procedure to close a hole in their heart (ASD or PFO closure)
- People who have previously had a procedure to close a small pouch in the heart called the left atrial appendage
- People who have an artificial (mechanical) mitral heart valve
- People who have not consistently taken their blood-thinning medication in the 3 weeks before the ablation procedure
- People who have kidney disease with a kidney function score (eGFR) below 45 ml (confirm with trial site)
- People whose heart's upper left chamber is enlarged beyond certain measurements, as assessed by a heart scan (confirm with trial site)
- People who have a known medical reason why catheter ablation would not be safe for them
- People who have a known medical reason why deep sedation or general anaesthesia would not be safe for them
- People who are known to be pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lucas VA Boersma, MD, PhD, St. Antonius Hospital
Phone: +31883200900
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Freedom of atrial fibrillation after a 2-month blanking period up to 18 months post procedure.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.